[1]Patent:US6218385,2001,B1
Title: 5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP.
Journal: Bioorganic & medicinal chemistry letters 20120615
22098-62-0 | (1H-Imidazol-2-yl)(phenyl)methanol | AA00706R | MFCD00840026
13436-48-1 | 1-Methyl-1H-indazole | AA0070MQ | MFCD00661658
13625-51-9 | 4-Methyl-4h-1,2,4-triazole-3,5-dithiol | AA007114 | MFCD10686675
445-83-0 | 4-Fluoro-2-nitroanisole | AA0071HG | MFCD00013375
4671-93-6 | SELENOCYANIC ACID BENZYL ESTER | AA0071YH | MFCD01684313
423753-00-8 | (E)-3-(2-Bromo-4-ethoxy-5-methoxyphenyl)acrylic acid | AA0072FY | MFCD02212599
438585-93-4 | (E)-1-Fluoro-3-(2-methoxyvinyl)benzene | AA0072TI | MFCD18825197
41051-14-3 | Butanoic acid,4-ethoxy-3-oxo-, ethyl ester | AA0073AF | MFCD00129120
196202-01-4 | Pentanoic acid,2,2-difluoro-3-oxo-, methyl ester | AA0073T6 | MFCD00792443
3937-94-8 | 2-((4-Nitrophenyl)sulfonyl)acetic acid | AA00749W | MFCD03983033
Journal: Bioorganic & medicinal chemistry letters20120615